» Articles » PMID: 17371806

Genetic Approaches Identify Differential Roles for Alpha4beta2* Nicotinic Receptors in Acute Models of Antinociception in Mice

Overview
Specialty Pharmacology
Date 2007 Mar 21
PMID 17371806
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of nicotine on the tail-flick and hot-plate tests were determined to identify nicotinic receptor subtypes responsible for spinally and supraspinally mediated nicotine analgesia in knockin mice expressing hypersensitive alpha(4) nicotinic receptors (L9'S), in seven inbred mouse strains (C57BL/6, DBA/2, A/2, CBA/2, BALB/cByJ, C3H/HeJ, and 129/SvEv), and in two F1 hybrids (B6CBAF1 and B6D2F1). L9'S heterozygotes were approximately 6-fold more sensitive to the antinociceptive effects of nicotine than the wild-type controls in the hot-plate test but not in the tail-flick assay. Large differences in the effects of nicotine were also observed with both tests for the seven mouse strains. A/J and 129 mice were 6- to 8-fold more sensitive than CBA and BALB mice. In addition, B6CBAF1 hybrid mice were even less sensitive than CBA mice. Nicotinic binding sites were measured in three spinal cord regions and the hindbrain of the inbred strains. Significant differences in cytisine-sensitive, high affinity [(125)I]epibatidine binding site levels (alpha(4)beta(2)(*) subtypes), but not in (125)I-alpha-bungarotoxin binding (alpha(7)(*) subtypes), were observed. Significant negative correlations between cytisine-sensitive [(125)I]epibatidine binding and nicotine ED(50) for both tests were noted. Our results indicate that alpha(4)beta(2)(*) acetylcholine nicotinic receptors (nAChR) are important in mediating nicotine analgesia in supraspinal responses, while also showing that alpha(4)beta(2)(*)-nAChR and at least one other nAChR subtype appear to modulate spinal actions.

Citing Articles

Consensus statement on smoking cessation in patients with pain.

Iida H, Yamaguchi S, Goyagi T, Sugiyama Y, Taniguchi C, Matsubara T J Anesth. 2022; 36(6):671-687.

PMID: 36069935 PMC: 9666296. DOI: 10.1007/s00540-022-03097-w.


Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives.

Corrie L, Stokes C, Wilkerson J, Carroll F, McMahon L, Papke R Mol Pharmacol. 2020; 98(4):328-342.

PMID: 32690626 PMC: 7485586. DOI: 10.1124/molpharm.120.000037.


Partial and full deletion of nicotinic acetylcholine receptor α4 and β2 subunits reduces sensitivity to acute nicotine administration and development of tolerance following chronic nicotine administration.

Marks M, Loetz E, Ortiz N, Herder P, Collins A Behav Pharmacol. 2020; 31(7):688-701.

PMID: 32568759 PMC: 7492369. DOI: 10.1097/FBP.0000000000000575.


Dynamics and Interactions of GPI-Linked lynx1 Protein with/without Nicotinic Acetylcholine Receptor in Membrane Bilayers.

Dong C, Kern N, Anderson K, Zhang X, Miwa J, Im W J Phys Chem B. 2020; 124(20):4017-4025.

PMID: 32208709 PMC: 7820712. DOI: 10.1021/acs.jpcb.0c00159.


C57BL/6 Substrain Differences in Pharmacological Effects after Acute and Repeated Nicotine Administration.

Akinola L, McKiver B, Toma W, Zhu A, Tyndale R, Kumar V Brain Sci. 2019; 9(10).

PMID: 31546627 PMC: 6827359. DOI: 10.3390/brainsci9100244.